Sorrento Therapeutics logo

Sorrento Therapeutics Funding & Investors

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.

sorrentotherapeutics.com

Total Amount Raised: $150,000,000

Sorrento Therapeutics Funding Rounds

  • Post Ipo Equity

    $150,000,000

    Post Ipo Equity Investors

    Ally Bridge Group
  • IPO

    Unknown

Funding info provided by Diffbot.